Ulipristal (Esmya) for preoperative treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age

The applicant claims that treatment with ulipristal is a cost-effective intervention for the preoperative treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.
The CG concludes that the cost-effectiveness of ulipristal in the preoperative treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age has been sufficiently substantiated.

This report is a summary of recommendations by the National Health Care Institute. The original text is in Dutch.